- Home
- ITRM vs TURN Comparison
ITRM vs TURN Comparison
Compare ITRM & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- TURN
- Stock Information
- Founded
- ITRM 2015
- TURN 1981
- Country
- ITRM Ireland
- TURN United States
- Employees
- ITRM N/A
- TURN N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- ITRM Health Care
- TURN Finance
- Exchange
- ITRM Nasdaq
- TURN Nasdaq
- Market Cap
- ITRM 40.0M
- TURN 46.3M
- IPO Year
- ITRM 2018
- TURN N/A
- Fundamental
- Price
- ITRM $0.76
- TURN $4.50
- Analyst Decision
- ITRM Strong Buy
- TURN
- Analyst Count
- ITRM 2
- TURN 0
- Target Price
- ITRM $7.00
- TURN N/A
- AVG Volume (30 Days)
- ITRM 1.0M
- TURN 23.4K
- Earning Date
- ITRM 08-05-2025
- TURN 01-01-0001
- Dividend Yield
- ITRM N/A
- TURN N/A
- EPS Growth
- ITRM N/A
- TURN N/A
- EPS
- ITRM N/A
- TURN N/A
- Revenue
- ITRM N/A
- TURN $194,813.00
- Revenue This Year
- ITRM N/A
- TURN N/A
- Revenue Next Year
- ITRM $270.19
- TURN N/A
- P/E Ratio
- ITRM N/A
- TURN N/A
- Revenue Growth
- ITRM N/A
- TURN 254.25
- 52 Week Low
- ITRM $0.66
- TURN $3.12
- 52 Week High
- ITRM $3.02
- TURN $4.72
- Technical
- Relative Strength Index (RSI)
- ITRM 41.71
- TURN 63.47
- Support Level
- ITRM $0.80
- TURN $4.35
- Resistance Level
- ITRM $0.91
- TURN $4.72
- Average True Range (ATR)
- ITRM 0.06
- TURN 0.11
- MACD
- ITRM 0.02
- TURN 0.02
- Stochastic Oscillator
- ITRM 41.08
- TURN 53.19
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.